MetaADEDB 2.0 @ LMMD
Voriconazole
(BCEHBSKCWLPMDN-MGPLVRAMSA-N)
Structure
SMILES
Fc1ccc(c(c1)F)[C@]([C@H](c1ncncc1F)C)(Cn1cncn1)O
Type(s)
Approved; Investigational
ATC code(s)
J02AC03
Molecular Formula:
C16H14F3N5O
Molecular Weight:
349.310
Log P:
2.1769
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
76.72
CAS Number(s):
137234-62-9; 188416-29-7
Synonym(s)
1.
Voriconazole
2.
UK 109,496
3.
UK 109496
4.
UK-109,496
5.
UK-109496
6.
Vfend
7.
UK109,496
8.
UK109496
External Link(s)
MeSHD065819
PubChem Compound71616
BindingDB50333117
ChEBI10023
CHEMBLCHEMBL638
DrugBankDB00582
DrugCentral2846
KEGGcpd:C07622
dr:D00578
Therapeutic Target DatabaseD0N3VR
ZINC14864
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 172
Canada Vigilance: 4
Canada Vigilance
US FAERS
2PneumoniaFAERS: 10819148589CTD
SIDER
US FAERS
3Disease ProgressionFAERS: 107
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
4Visual ImpairmentFAERS: 98
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
5MalaiseFAERS: 96SIDER
US FAERS
6PeriostitisFAERS: 73
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
7Drug level increasedFAERS: 61US FAERS
8DizzinessFAERS: 52SIDER
US FAERS
9Respiratory FailureFAERS: 52OFFSIDES
US FAERS
10NauseaFAERS: 50SIDER
US FAERS
11PhotophobiaFAERS: 45SIDER
US FAERS
12AstheniaFAERS: 44SIDER
US FAERS
13Product use issueFAERS: 41US FAERS
14InfectionFAERS: 37OFFSIDES
SIDER
US FAERS
15Altered state of consciousnessFAERS: 36US FAERS
16HeadacheFAERS: 35SIDER
US FAERS
17SepsisFAERS: 35
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
18Squamous cell carcinomaFAERS: 35SIDER
US FAERS
19BlindnessFAERS: 33US FAERS
20Drug resistanceFAERS: 32OFFSIDES
US FAERS
21treatment failureFAERS: 32US FAERS
22ArthralgiaFAERS: 31SIDER
US FAERS
23Bone painFAERS: 31
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24AspergillosisFAERS: 29

View details

CTD
OFFSIDES
US FAERS
25Mental status changesFAERS: 29US FAERS
26Weight decreasedFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
27MyalgiaFAERS: 28SIDER
US FAERS
28Product use in unapproved indicationFAERS: 28US FAERS
29Drug level below therapeuticFAERS: 26US FAERS
30Drug level decreasedFAERS: 26US FAERS
31Bronchopulmonary AspergillosisFAERS: 25US FAERS
32ErythemaFAERS: 25SIDER
US FAERS
33HepatotoxicityFAERS: 25OFFSIDES
US FAERS
34VomitingFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
35DeliriumFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
36PainFAERS: 2315642862
19457596
CTD
SIDER
US FAERS
37Pathogen resistanceFAERS: 23OFFSIDES
US FAERS
38nervous system disorderFAERS: 23SIDER
US FAERS
39FatigueFAERS: 22US FAERS
40No adverse eventFAERS: 22US FAERS
41RhabdomyolysisFAERS: 2116410267CTD
OFFSIDES
US FAERS
42Aspartate Aminotransferase IncreasedFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
43CheilitisFAERS: 20SIDER
US FAERS
44Disease recurrenceFAERS: 20US FAERS
45Feeling abnormalFAERS: 20SIDER
US FAERS
46General physical health deteriorationFAERS: 20US FAERS
47MucormycosisFAERS: 20US FAERS
48PruritusFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
49SomnolenceFAERS: 20SIDER
US FAERS
50Visual disturbanceFAERS: 20SIDER
US FAERS
51Actinic keratosisFAERS: 19US FAERS
52AlopeciaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
53Drug level above therapeuticFAERS: 19US FAERS
54TremorFAERS: 19SIDER
US FAERS
55Gamma-Glutamyltransferase IncreasedFAERS: 18OFFSIDES
US FAERS
56Septic ShockFAERS: 18OFFSIDES
US FAERS
57ZygomycosisFAERS: 18US FAERS
58DyschromatopsiaFAERS: 17US FAERS
59Memory impairmentFAERS: 17US FAERS
60NeutropeniaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
61Squamous cell carcinoma of skinFAERS: 17US FAERS
62AgitationFAERS: 16SIDER
US FAERS
63Alanine Aminotransferase IncreasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
64Cerebrovascular accidentFAERS: 16SIDER
US FAERS
65HypersensitivityFAERS: 16SIDER
US FAERS
66CholestasisFAERS: 15SIDER
US FAERS
67ChromatopsiaFAERS: 15SIDER
US FAERS
68InfluenzaFAERS: 15SIDER
US FAERS
69Transaminases increasedFAERS: 15OFFSIDES
US FAERS
70XanthopsiaFAERS: 15US FAERS
71Abdominal discomfortFAERS: 14US FAERS
72AgranulocytosisFAERS: 14SIDER
US FAERS
73AnxietyFAERS: 14SIDER
US FAERS
74Back PainFAERS: 14SIDER
US FAERS
75Blood alkaline phosphatase increasedFAERS: 14SIDER
US FAERS
76Fluoride increasedFAERS: 14US FAERS
77Impaired driving abilityFAERS: 14US FAERS
78PolyneuropathyFAERS: 14OFFSIDES
US FAERS
79Cardiac ArrestFAERS: 13SIDER
US FAERS
80Drug effect incompleteFAERS: 13US FAERS
81Retinal toxicityFAERS: 13SIDER
US FAERS
82Toxicity to various agentsFAERS: 12US FAERS
83Chest PainFAERS: 11SIDER
US FAERS
84DiplopiaFAERS: 11SIDER
US FAERS
85LymphomaFAERS: 11OFFSIDES
US FAERS
86Myocardial InfarctionFAERS: 11SIDER
US FAERS
87ThrombocytopeniaFAERS: 11SIDER
US FAERS
88DisorientationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Febrile NeutropeniaFAERS: 10OFFSIDES
US FAERS
90IleusFAERS: 10US FAERS
91Intentional product misuseFAERS: 10US FAERS
92PancreatitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
93White blood cell count decreasedFAERS: 10US FAERS
94Acute kidney injuryFAERS: 9
Canada Vigilance: 1
16410267CTD
Canada Vigilance
US FAERS
95Basal cell carcinomaFAERS: 9US FAERS
96CellulitisFAERS: 9SIDER
US FAERS
97ConstipationFAERS: 9SIDER
US FAERS
98DehydrationFAERS: 9US FAERS
99Depressed Level of ConsciousnessFAERS: 9OFFSIDES
US FAERS
100Drug dose omissionFAERS: 9US FAERS
101EpilepsyFAERS: 9US FAERS
102HypotensionFAERS: 9SIDER
US FAERS
103Intentional product use issueFAERS: 9US FAERS
104MYELODYSPLASTIC SYNDROMEFAERS: 9US FAERS
105Peripheral swellingFAERS: 9US FAERS
106Productive CoughFAERS: 9US FAERS
107PseudoporphyriaFAERS: 9SIDER
US FAERS
108Scedosporium infectionFAERS: 9US FAERS
109Solar dermatitisFAERS: 9US FAERS
110Therapeutic response unexpectedFAERS: 9US FAERS
111ThrombosisFAERS: 9US FAERS
112Abdominal PainFAERS: 8SIDER
US FAERS
113Aspergillus test positiveFAERS: 8US FAERS
114Blood creatinine increasedFAERS: 8OFFSIDES
SIDER
US FAERS
115Burning sensationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
116CandidiasisFAERS: 817653912
18627469
CTD
US FAERS
117DeafnessFAERS: 8SIDER
US FAERS
118DyspepsiaFAERS: 8SIDER
US FAERS
119HypoxiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
120LentigoFAERS: 8US FAERS
121Macular opacityFAERS: 8US FAERS
122Stem cell transplantFAERS: 8OFFSIDES
US FAERS
123Atrial FibrillationFAERS: 7SIDER
US FAERS
124Blood creatine phosphokinase increasedFAERS: 7SIDER
US FAERS
125BradycardiaFAERS: 715472801CTD
SIDER
US FAERS
126Dental cariesFAERS: 7US FAERS
127Drug administration errorFAERS: 7US FAERS
128Joint swellingFAERS: 7US FAERS
129OverdoseFAERS: 7US FAERS
130Pericardial effusionFAERS: 7OFFSIDES
US FAERS
131Porphyria non-acuteFAERS: 7US FAERS
132RestlessnessFAERS: 7US FAERS
133Skin lesionFAERS: 7SIDER
US FAERS
134Adverse eventFAERS: 6US FAERS
135AspergillomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
136Bacterial sepsisFAERS: 6US FAERS
137Blood albumin decreasedFAERS: 6US FAERS
138Complications of transplant surgeryFAERS: 6OFFSIDES
US FAERS
139Drug ineffective for unapproved indicationFAERS: 6US FAERS
140Dry skinFAERS: 6SIDER
US FAERS
141DysgeusiaFAERS: 6SIDER
US FAERS
142Medication ErrorFAERS: 6US FAERS
143Musculoskeletal stiffnessFAERS: 6US FAERS
144PalpitationsFAERS: 6SIDER
US FAERS
145PneumothoraxFAERS: 6OFFSIDES
US FAERS
146Pulmonary EmbolismFAERS: 6SIDER
US FAERS
147Pulmonary function test decreasedFAERS: 6US FAERS
148TachycardiaFAERS: 6SIDER
US FAERS
149TuberculosisFAERS: 6US FAERS
150Unevaluable eventFAERS: 6US FAERS
151Blood count abnormalFAERS: 5US FAERS
152Bowen's DiseaseFAERS: 5OFFSIDES
US FAERS
153BronchitisFAERS: 5US FAERS
154CachexiaFAERS: 5US FAERS
155ChloropsiaFAERS: 5US FAERS
156ChokingFAERS: 5US FAERS
157Hallucinations, mixedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
158HyperkeratosisFAERS: 5US FAERS
159IncoherentFAERS: 5US FAERS
160Lung transplant rejectionFAERS: 5US FAERS
161Malignant neoplasm progressionFAERS: 5OFFSIDES
US FAERS
162MetamorphopsiaFAERS: 5US FAERS
163NasopharyngitisFAERS: 5US FAERS
164Neck PainFAERS: 5US FAERS
165Nephrotic SyndromeFAERS: 5SIDER
US FAERS
166OsteomyelitisFAERS: 5US FAERS
167Prescribed overdoseFAERS: 5US FAERS
168Respiratory distressFAERS: 5SIDER
US FAERS
169Stevens-Johnson SyndromeFAERS: 5
Canada Vigilance: 2
25811541CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
170StomatitisFAERS: 5SIDER
US FAERS
171SunburnFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
172SwellingFAERS: 5US FAERS
173SyncopeFAERS: 5SIDER
US FAERS
174TransplantFAERS: 5US FAERS
175Activities of daily living impairedFAERS: 4US FAERS
176ArthropathyFAERS: 4US FAERS
177BedriddenFAERS: 4OFFSIDES
US FAERS
178Blood lactate dehydrogenase increasedFAERS: 4US FAERS
179Blood potassium abnormalFAERS: 4US FAERS
180Blood potassium decreasedFAERS: 4OFFSIDES
US FAERS
181CataractFAERS: 4US FAERS
182CholecystitisFAERS: 4SIDER
US FAERS
183Diabetes MellitusFAERS: 4US FAERS
184DysarthriaFAERS: 4US FAERS
185ErythropsiaFAERS: 4US FAERS
186Eye InfectionFAERS: 4US FAERS
187GlomerulonephritisFAERS: 4OFFSIDES
US FAERS
188HydrothoraxFAERS: 4US FAERS
189Incorrect dose administeredFAERS: 4US FAERS
190Lemierre SyndromeFAERS: 4US FAERS
191LeukopeniaFAERS: 4SIDER
US FAERS
192Lower respiratory tract infectionFAERS: 4US FAERS
193MalabsorptionFAERS: 4US FAERS
194Muscle tightnessFAERS: 4US FAERS
195Musculoskeletal PainFAERS: 4US FAERS
196NecrosisFAERS: 4US FAERS
197NervousnessFAERS: 4US FAERS
198NeuralgiaFAERS: 4SIDER
US FAERS
199Oropharyngeal painFAERS: 4SIDER
US FAERS
200PancytopeniaFAERS: 4SIDER
US FAERS
201PeriarthritisFAERS: 4US FAERS
202Poor quality sleepFAERS: 4US FAERS
203Pulmonary FibrosisFAERS: 4US FAERS
204Pulmonary HypertensionFAERS: 4US FAERS
205Rash erythematousFAERS: 4US FAERS
206Sudden deathFAERS: 4US FAERS
207TinnitusFAERS: 4SIDER
US FAERS
208jaundiceFAERS: 4SIDER
US FAERS
209Ammonia increasedFAERS: 3US FAERS
210Anaphylactic shockFAERS: 3SIDER
US FAERS
211AngioedemaFAERS: 3SIDER
US FAERS
212AnorexiaFAERS: 3SIDER
US FAERS
213AphasiaFAERS: 3US FAERS
214Capillary Leak SyndromeFAERS: 3OFFSIDES
US FAERS
215Cerebral aspergillosisFAERS: 3US FAERS
216Cerebral disorderFAERS: 3US FAERS
217Chest discomfortFAERS: 3SIDER
US FAERS
218ChromaturiaFAERS: 3US FAERS
219Creatinine renal clearance decreasedFAERS: 3SIDER
US FAERS
220Device related infectionFAERS: 3US FAERS
221Drug dispensing errorFAERS: 3US FAERS
222Drug effect delayedFAERS: 3US FAERS
223DysphoniaFAERS: 3US FAERS
224EncephalitisFAERS: 3SIDER
US FAERS
225EosinophiliaFAERS: 3SIDER
US FAERS
226EpistaxisFAERS: 3SIDER
US FAERS
227ExophthalmosFAERS: 3US FAERS
228Eye painFAERS: 3SIDER
US FAERS
229Facial PainFAERS: 3US FAERS
230Feeling jitteryFAERS: 3US FAERS
231FlushingFAERS: 3SIDER
US FAERS
232Full blood count decreasedFAERS: 3US FAERS
233Gait inabilityFAERS: 3US FAERS
234GlaucomaFAERS: 3US FAERS
235Hepatic EncephalopathyFAERS: 3US FAERS
236Intestinal ObstructionFAERS: 3US FAERS
237LeukocytosisFAERS: 3US FAERS
238Lip swellingFAERS: 3US FAERS
239Lower respiratory tract infection viralFAERS: 3US FAERS
240LymphadenopathyFAERS: 3SIDER
US FAERS
241MELAS SyndromeFAERS: 3US FAERS
242MeningitisFAERS: 3US FAERS
243Mental impairmentFAERS: 3US FAERS
244Myasthenia GravisFAERS: 3US FAERS
245Ocular discomfortFAERS: 3US FAERS
246PneumonitisFAERS: 3US FAERS
247Post procedural complicationFAERS: 3US FAERS
248Product quality issueFAERS: 3US FAERS
249PrurigoFAERS: 3US FAERS
250Retinal DetachmentFAERS: 3US FAERS
251Retinal Vein OcclusionFAERS: 3US FAERS
252Retinal exudatesFAERS: 3US FAERS
253ShockFAERS: 3SIDER
US FAERS
254Sinus TachycardiaFAERS: 3US FAERS
255Skin discomfortFAERS: 3US FAERS
256Skin reactionFAERS: 3US FAERS
257Skin tightnessFAERS: 3US FAERS
258Skin toxicityFAERS: 3US FAERS
259Solar lentigoFAERS: 3US FAERS
260Toxic Epidermal NecrolysisFAERS: 3SIDER
US FAERS
261TracheobronchitisFAERS: 3US FAERS
262Unresponsive to stimuliFAERS: 3US FAERS
263Vitreous floatersFAERS: 3US FAERS
264Wrong technique in drug usage processFAERS: 3US FAERS
265AcidosisFAERS: 2OFFSIDES
US FAERS
266Acquired Immunodeficiency SyndromeFAERS: 2US FAERS
267AgeusiaFAERS: 2SIDER
US FAERS
268Altered visual depth perceptionFAERS: 2US FAERS
269AmaurosisFAERS: 2US FAERS
270AmnesiaFAERS: 2OFFSIDES
SIDER
US FAERS
271AnoxiaFAERS: 2US FAERS
272ApathyFAERS: 2US FAERS
273AphoniaFAERS: 2US FAERS
274Apparent deathFAERS: 2US FAERS
275AsthenopiaFAERS: 2US FAERS
276AsthmaFAERS: 2US FAERS
277AtaxiaFAERS: 2SIDER
US FAERS
278Atrial FlutterFAERS: 2OFFSIDES
US FAERS
279Blood amylase increasedFAERS: 2US FAERS
280Blood magnesium decreasedFAERS: 2US FAERS
281BronchospasmFAERS: 2US FAERS
282CarcinomaFAERS: 2US FAERS
283Cell DeathFAERS: 2US FAERS
284ChillsFAERS: 2SIDER
US FAERS
285CholelithiasisFAERS: 2SIDER
US FAERS
286Conversion disorderFAERS: 2US FAERS
287Cytolytic hepatitisFAERS: 2US FAERS
288Deep Vein ThrombosisFAERS: 2US FAERS
289DementiaFAERS: 2SIDER
US FAERS
290Dermatitis acneiformFAERS: 2US FAERS
291DermatomyositisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Diabetes InsipidusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
293Disseminated Intravascular CoagulationFAERS: 2OFFSIDES
SIDER
US FAERS
294Drug level changedFAERS: 2US FAERS
295Drug level fluctuatingFAERS: 2US FAERS
296Drug toxicityFAERS: 2US FAERS
297EczemaFAERS: 2SIDER
US FAERS
298Ejection Fraction DecreasedFAERS: 2US FAERS
299Electrolyte imbalanceFAERS: 2US FAERS
300Embolic strokeFAERS: 2US FAERS
301Emotional disorderFAERS: 2US FAERS
302Enterococcal infectionFAERS: 2US FAERS
303Epstein-Barr virus test positiveFAERS: 2US FAERS
304Expired product administeredFAERS: 2US FAERS
305Extremity necrosisFAERS: 2US FAERS
306Eye BurnsFAERS: 2US FAERS
307Gastrointestinal perforationFAERS: 2US FAERS
308HemiparesisFAERS: 2US FAERS
309HepatosplenomegalyFAERS: 2US FAERS
310HypercapniaFAERS: 2OFFSIDES
US FAERS
311HypokinesiaFAERS: 2US FAERS
312Impaired work abilityFAERS: 2US FAERS
313Incorrect route of drug administrationFAERS: 2US FAERS
314InflammationFAERS: 2SIDER
US FAERS
315Infusion site erythemaFAERS: 2US FAERS
316Intentional dose omissionFAERS: 2US FAERS
317IritisFAERS: 2US FAERS
318Joint injuryFAERS: 2US FAERS
319Lactose IntoleranceFAERS: 2US FAERS
320Large intestine perforationFAERS: 2US FAERS
321LeukoencephalopathyFAERS: 2OFFSIDES
US FAERS
322Limb discomfortFAERS: 2US FAERS
323Liver AbscessFAERS: 2US FAERS
324Lower respiratory tract infection bacterialFAERS: 2US FAERS
325Macular degenerationFAERS: 2US FAERS
326Mental disorder due to a general medical conditionFAERS: 2US FAERS
327Metabolic acidosisFAERS: 2OFFSIDES
US FAERS
328MonoplegiaFAERS: 2US FAERS
329Multiple SclerosisFAERS: 2US FAERS
330Mycobacterium abscessus InfectionFAERS: 2US FAERS
331MydriasisFAERS: 2SIDER
US FAERS
332Myocardial necrosis marker increasedFAERS: 2US FAERS
333MyositisFAERS: 2US FAERS
334Nerve injuryFAERS: 2US FAERS
335Night sweatsFAERS: 2US FAERS
336OliguriaFAERS: 2SIDER
US FAERS
337OnycholysisFAERS: 2US FAERS
338OphthalmoplegiaFAERS: 2US FAERS
339Optic NeuritisFAERS: 2SIDER
US FAERS
340Optic NeuropathyFAERS: 2US FAERS
341Osteitis DeformansFAERS: 2US FAERS
342OsteosclerosisFAERS: 2US FAERS
343PharyngitisFAERS: 2SIDER
US FAERS
344PleurisyFAERS: 2US FAERS
345Polyomavirus-associated nephropathyFAERS: 2US FAERS
346Pre-existing condition improvedFAERS: 2US FAERS
347Precancerous skin lesionFAERS: 2US FAERS
348Prescription drug used without a prescriptionFAERS: 2US FAERS
349Product contaminationFAERS: 2US FAERS
350Protein total decreasedFAERS: 2US FAERS
351Prothrombin level decreasedFAERS: 2US FAERS
352Pseudomonal sepsisFAERS: 2US FAERS
353Psychiatric symptomFAERS: 2US FAERS
354Pulmonary thrombosisFAERS: 2US FAERS
355Pupillary light reflex tests abnormalFAERS: 2US FAERS
356Red man syndromeFAERS: 2US FAERS
357Rheumatoid ArthritisFAERS: 2US FAERS
358ScleritisFAERS: 2SIDER
US FAERS
359Scopulariopsis infectionFAERS: 2US FAERS
360Skin irritationFAERS: 2US FAERS
361Sleep TalkingFAERS: 2US FAERS
362Supraventricular tachycardiaFAERS: 2OFFSIDES
SIDER
US FAERS
363Therapy partial responderFAERS: 2US FAERS
364Thermal burnFAERS: 2US FAERS
365Urinary RetentionFAERS: 2SIDER
US FAERS
366UrticariaFAERS: 2SIDER
US FAERS
367Ventricular FibrillationFAERS: 2OFFSIDES
SIDER
US FAERS
368WheezingFAERS: 2US FAERS
369White blood cell count abnormalFAERS: 2US FAERS
370Wrong technique in product usage processFAERS: 2US FAERS
371AbasiaFAERS: 1OFFSIDES
US FAERS
372AbscessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
373Acanthamoeba InfectionFAERS: 1US FAERS
374Accidental overdoseFAERS: 1US FAERS
375Acquired night blindnessFAERS: 1US FAERS
376Acquired porphyriaFAERS: 1US FAERS
377Adenosquamous cell lung cancerFAERS: 1US FAERS
378Alcohol withdrawal syndromeFAERS: 1US FAERS
379Alternaria infectionFAERS: 1US FAERS
380Amaurosis FugaxFAERS: 1US FAERS
381AmputationFAERS: 1US FAERS
382AmyloidosisFAERS: 1US FAERS
383Anal FissureFAERS: 1US FAERS
384Anal FistulaFAERS: 1US FAERS
385AngerFAERS: 1US FAERS
386Angina PectorisFAERS: 1US FAERS
387Ankle FractureFAERS: 1US FAERS
388Antibiotic level below therapeuticFAERS: 1US FAERS
389AnuriaFAERS: 1OFFSIDES
SIDER
US FAERS
390AortitisFAERS: 1US FAERS
391ArthritisFAERS: 1SIDER
US FAERS
392AscitesFAERS: 1OFFSIDES
SIDER
US FAERS
393AtelectasisFAERS: 1OFFSIDES
US FAERS
394Atrioventricular BlockFAERS: 1US FAERS
395Axonal neuropathyFAERS: 1US FAERS
396Back disorderFAERS: 1US FAERS
397Biliary dilatationFAERS: 1US FAERS
398Bilirubin conjugated increasedFAERS: 1US FAERS
399Biopsy liver abnormalFAERS: 1US FAERS
400Bipolar I disorderFAERS: 1US FAERS
401Bladder painFAERS: 1US FAERS
402BlepharitisFAERS: 1SIDER
US FAERS
403Blood alkaline phosphatase abnormalFAERS: 1US FAERS
404Blood beta-D-glucan abnormalFAERS: 1US FAERS
405Blood beta-D-glucan increasedFAERS: 1OFFSIDES
US FAERS
406Blood bilirubin abnormalFAERS: 1US FAERS
407Blood blisterFAERS: 1US FAERS
408Blood calcium abnormalFAERS: 1US FAERS
409Blood cortisol decreasedFAERS: 1US FAERS
410Blood creatinine abnormalFAERS: 1US FAERS
411Blood creatinine decreasedFAERS: 1US FAERS
412Blood glucose decreasedFAERS: 1US FAERS
413Blood iron abnormalFAERS: 1US FAERS
414Blood iron decreasedFAERS: 1US FAERS
415Blood potassium increasedFAERS: 1US FAERS
416Blood sodium decreasedFAERS: 1US FAERS
417Blood testosterone decreasedFAERS: 1US FAERS
418Blood triglycerides increasedFAERS: 1US FAERS
419Bone abscessFAERS: 1US FAERS
420Bone formation decreasedFAERS: 1US FAERS
421Bone lesionFAERS: 1US FAERS
422Bone marrow transplant rejectionFAERS: 1US FAERS
423BradyphreniaFAERS: 1US FAERS
424Brain AbscessFAERS: 1US FAERS
425Breast cancer recurrentFAERS: 1US FAERS
426BronchiectasisFAERS: 1US FAERS
427Bronchopleural FistulaFAERS: 1US FAERS
428BronchopneumoniaFAERS: 1US FAERS
429Bronchoscopy abnormalFAERS: 1US FAERS
430Candida sepsisFAERS: 1US FAERS
431CarcinogenicityFAERS: 1US FAERS
432Cardiac DeathFAERS: 1US FAERS
433Cardiac FlutterFAERS: 1US FAERS
434Cardiomyopathy acuteFAERS: 1US FAERS
435Central nervous system lesionFAERS: 1US FAERS
436Cerebral InfarctionFAERS: 1US FAERS
437ChemotherapyFAERS: 1US FAERS
438CholangitisFAERS: 1US FAERS
439Cholecystitis infectiveFAERS: 1US FAERS
440Choroidal dystrophyFAERS: 1US FAERS
441Chronic granulomatous diseaseFAERS: 1OFFSIDES
US FAERS
442Chronic respiratory failureFAERS: 1US FAERS
443Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
444CoccidioidomycosisFAERS: 1OFFSIDES
US FAERS
445Cold sweatFAERS: 1US FAERS
446ColitisFAERS: 1US FAERS
447Completed SuicideFAERS: 1US FAERS
448Complications of bone marrow transplantFAERS: 1US FAERS
449Concomitant disease aggravatedFAERS: 1US FAERS
450Coronary Artery DiseaseFAERS: 1US FAERS
451Critical IllnessFAERS: 1US FAERS
452CryingFAERS: 1US FAERS
453CyanopsiaFAERS: 1US FAERS
454CyanosisFAERS: 1SIDER
US FAERS
455Cytokine stormFAERS: 1US FAERS
456Deafness NeurosensoryFAERS: 1US FAERS
457Delirium febrileFAERS: 1US FAERS
458Delusional disorder, unspecified typeFAERS: 1US FAERS
459DependenceFAERS: 1US FAERS
460Depressed moodFAERS: 1US FAERS
461DiplegiaFAERS: 1US FAERS
462DiscomfortFAERS: 1SIDER
US FAERS
463DiverticulitisFAERS: 1US FAERS
464Drug abuseFAERS: 1US FAERS
465Drug exposure during pregnancyFAERS: 1US FAERS
466Drug prescribing errorFAERS: 1US FAERS
467DysuriaFAERS: 1SIDER
US FAERS
468EcchymosisFAERS: 1SIDER
US FAERS
469Ectopic PregnancyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
470EmbolismFAERS: 1US FAERS
471Emotional distressFAERS: 1US FAERS
472EmpyemaFAERS: 1OFFSIDES
US FAERS
473EndophthalmitisFAERS: 1OFFSIDES
US FAERS
474EnteritisFAERS: 1US FAERS
475Enterobacter pneumoniaFAERS: 1US FAERS
476Erectile dysfunctionFAERS: 1SIDER
US FAERS
477Erythema MultiformeFAERS: 1SIDER
US FAERS
478Escherichia sepsisFAERS: 1US FAERS
479Euphoric moodFAERS: 1SIDER
US FAERS
480Excessive eye blinkingFAERS: 1US FAERS
481Extra dose administeredFAERS: 1US FAERS
482Eyelid irritationFAERS: 1US FAERS
483Failure to ThriveFAERS: 1US FAERS
484FolliculitisFAERS: 1US FAERS
485FormicationFAERS: 1US FAERS
486FractureFAERS: 1US FAERS
487Fungal peritonitisFAERS: 1US FAERS
488Fungal retinitisFAERS: 1US FAERS
489Fungal test positiveFAERS: 1OFFSIDES
US FAERS
490Fungus sputum test positiveFAERS: 1US FAERS
491Gamma-glutamyltransferase abnormalFAERS: 1US FAERS
492Gastric ulcerFAERS: 1SIDER
US FAERS
493Gastroenteritis norovirusFAERS: 1US FAERS
494GastroenteritisFAERS: 1SIDER
US FAERS
495Gastrointestinal PainFAERS: 1SIDER
US FAERS
496Gastrointestinal hypomotilityFAERS: 1US FAERS
497Gastrointestinal motility disorderFAERS: 1US FAERS
498Gastrointestinal obstructionFAERS: 1US FAERS
499Glioblastoma MultiformeFAERS: 1US FAERS
500GlossitisFAERS: 1SIDER
US FAERS
501GlycosuriaFAERS: 1SIDER
US FAERS
502Guillain-Barre SyndromeFAERS: 1SIDER
US FAERS
503HemiplegiaFAERS: 1US FAERS
504Hepatic candidiasisFAERS: 1US FAERS
505HepatitisFAERS: 1SIDER
US FAERS
506HepatomegalyFAERS: 1SIDER
US FAERS
507Histiocytosis haematophagicFAERS: 1OFFSIDES
US FAERS
508HostilityFAERS: 1US FAERS
509HypertransaminasaemiaFAERS: 1US FAERS
510Hypertrophic osteoarthropathyFAERS: 1US FAERS
511HyperventilationFAERS: 1US FAERS
512HypothyroidismFAERS: 1SIDER
US FAERS
513HypotrichosisFAERS: 1US FAERS
514Immediate post-injection reactionFAERS: 1US FAERS
515Immune reconstitution syndromeFAERS: 1US FAERS
516ImmunosuppressionFAERS: 1US FAERS
517Incorrect product administration durationFAERS: 1US FAERS
518Incorrect route of product administrationFAERS: 1US FAERS
519Increased tendency to bruiseFAERS: 1US FAERS
520Increased upper airway secretionFAERS: 1US FAERS
521Increased viscosity of bronchial secretionFAERS: 1US FAERS
522InfarctionFAERS: 1US FAERS
523Infection in an immunocompromised hostFAERS: 1US FAERS
524Inflammatory marker increasedFAERS: 1US FAERS
525Infusion site infectionFAERS: 1US FAERS
526Injection site extravasationFAERS: 1US FAERS
527Intentional drug misuseFAERS: 1US FAERS
528Intracranial AneurysmFAERS: 1US FAERS
529IntussusceptionFAERS: 1US FAERS
530Joint abscessFAERS: 1US FAERS
531Labile blood pressureFAERS: 1US FAERS
532Lack of spontaneous speechFAERS: 1US FAERS
533LaryngitisFAERS: 1US FAERS
534LethargyFAERS: 1US FAERS
535Limb massFAERS: 1US FAERS
536Lip neoplasm malignant stage unspecifiedFAERS: 1US FAERS
537Lipase increasedFAERS: 1US FAERS
538Lower respiratory tract infection fungalFAERS: 1US FAERS
539Lung adenocarcinoma recurrentFAERS: 1US FAERS
540Lupus NephritisFAERS: 1US FAERS
541Lupus-like syndromeFAERS: 1US FAERS
542Macular pigmentationFAERS: 1US FAERS
543MalnutritionFAERS: 1SIDER
US FAERS
544MastoiditisFAERS: 1US FAERS
545Medication monitoring errorFAERS: 1US FAERS
546Mucosal necrosisFAERS: 1US FAERS
547Multiple MyelomaFAERS: 1US FAERS
548Muscle strainFAERS: 1US FAERS
549Mycobacterium kansasii pneumoniaFAERS: 1US FAERS
550MyelitisFAERS: 1US FAERS
551MyocarditisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
552MyoclonusFAERS: 1US FAERS
553MyopiaFAERS: 1US FAERS
554Nail InfectionFAERS: 1US FAERS
555Nail pigmentationFAERS: 1US FAERS
556Nasal discomfortFAERS: 1US FAERS
557Nerve Root CompressionFAERS: 1US FAERS
558Neuroleptic Malignant SyndromeFAERS: 1US FAERS
559NeuropathyFAERS: 1SIDER
US FAERS
560Neutropenic sepsisFAERS: 1US FAERS
561Neutrophil count decreasedFAERS: 1US FAERS
562Nipple painFAERS: 1US FAERS
563No adverse effectFAERS: 1US FAERS
564NystagmusFAERS: 1SIDER
US FAERS
565ObesityFAERS: 1US FAERS
566Obsessive-Compulsive DisorderFAERS: 1US FAERS
567OpisthotonusFAERS: 1US FAERS
568Oral fungal infectionFAERS: 1US FAERS
569Oral painFAERS: 1US FAERS
570OsteolysisFAERS: 1US FAERS
571OsteopeniaFAERS: 1US FAERS
572PO2 decreasedFAERS: 1US FAERS
573Pain of skinFAERS: 1US FAERS
574Pancreatic InsufficiencyFAERS: 1US FAERS
575PapuleFAERS: 1US FAERS
576ParanoiaFAERS: 1US FAERS
577Parenteral NutritionFAERS: 1US FAERS
578ParophthalmiaFAERS: 1US FAERS
579Parotid gland inflammationFAERS: 1US FAERS
580PeritonitisFAERS: 1OFFSIDES
SIDER
US FAERS
581Personality ChangeFAERS: 1US FAERS
582PetechiaeFAERS: 1SIDER
US FAERS
583PhotodermatosisFAERS: 1US FAERS
584Platelet count abnormalFAERS: 1US FAERS
585Pleuritic painFAERS: 1US FAERS
586Pneumatosis intestinalisFAERS: 1US FAERS
587PolyuriaFAERS: 1US FAERS
588PregnancyFAERS: 1US FAERS
589Primary Adrenal InsufficiencyFAERS: 1US FAERS
590Procedural complicationFAERS: 1US FAERS
591Procedural hypertensionFAERS: 1US FAERS
592Product container issueFAERS: 1US FAERS
593Product counterfeitFAERS: 1US FAERS
594Product lot number issueFAERS: 1US FAERS
595Product packaging issueFAERS: 1US FAERS
596Product prescribing issueFAERS: 1US FAERS
597Pulmonary congestionFAERS: 1OFFSIDES
US FAERS
598Pulmonary painFAERS: 1US FAERS
599PurpuraFAERS: 1SIDER
US FAERS
600QuadriparesisFAERS: 1US FAERS
601RalesFAERS: 1US FAERS
602Rash scalyFAERS: 1US FAERS
603Reaction to drug excipientsFAERS: 1US FAERS
604Renal cell carcinoma recurrentFAERS: 1US FAERS
605Renal painFAERS: 1SIDER
US FAERS
606Respiratory arrestFAERS: 1US FAERS
607Respiratory fatigueFAERS: 1US FAERS
608Respiratory syncytial virus bronchitisFAERS: 1US FAERS
609Respiratory tract congestionFAERS: 1US FAERS
610Respiratory tract infection fungalFAERS: 1US FAERS
611Retinal Vascular DisorderFAERS: 1US FAERS
612Retinal phototoxicityFAERS: 1US FAERS
613Right ventricular failureFAERS: 1US FAERS
614SalpingitisFAERS: 1US FAERS
615SarcoidosisFAERS: 1US FAERS
616ScabFAERS: 1US FAERS
617SchizophreniaFAERS: 1US FAERS
618SciaticaFAERS: 1US FAERS
619Shock symptomFAERS: 1US FAERS
620Sinus operationFAERS: 1US FAERS
621SinusitisFAERS: 1SIDER
US FAERS
622Sitting disabilityFAERS: 1US FAERS
623Skin IndurationFAERS: 1US FAERS
624Skin WrinklingFAERS: 1US FAERS
625Skin hypertrophyFAERS: 1US FAERS
626Skin necrosisFAERS: 1US FAERS
627SluggishnessFAERS: 1US FAERS
628SplenomegalyFAERS: 1SIDER
US FAERS
629Sputum retentionFAERS: 1US FAERS
630Status EpilepticusFAERS: 1US FAERS
631Subcutaneous AbscessFAERS: 1US FAERS
632Suspected counterfeit productFAERS: 1US FAERS
633Systemic mycosisFAERS: 1US FAERS
634T-Cell LymphomaFAERS: 1US FAERS
635Teeth brittleFAERS: 1US FAERS
636TensionFAERS: 1US FAERS
637Therapy cessationFAERS: 1US FAERS
638Therapy non-responderFAERS: 1US FAERS
639Therapy regimen changedFAERS: 1US FAERS
640ThirstFAERS: 1US FAERS
641TonsillitisFAERS: 1US FAERS
642Tracheal massFAERS: 1US FAERS
643Traumatic lumbar punctureFAERS: 1US FAERS
644Trichosporon infectionFAERS: 1US FAERS
645Trigeminal NeuralgiaFAERS: 1US FAERS
646UlcerFAERS: 1US FAERS
647Umbilical dischargeFAERS: 1US FAERS
648Urinary IncontinenceFAERS: 1SIDER
US FAERS
649Urinary tract infection fungalFAERS: 1US FAERS
650Urinary tract infectionFAERS: 1SIDER
US FAERS
651Urinary tract obstructionFAERS: 1US FAERS
652Urine output increasedFAERS: 1US FAERS
653Urticarial vasculitisFAERS: 1US FAERS
654UveitisFAERS: 1SIDER
US FAERS
655VIth nerve paresisFAERS: 1US FAERS
656Venoocclusive diseaseFAERS: 1US FAERS
657Ventricular arrhythmiaFAERS: 1SIDER
US FAERS
658Visual acuity tests abnormalFAERS: 1US FAERS
659Visual brightnessFAERS: 1US FAERS
660VitritisFAERS: 1US FAERS
661Walking aid userFAERS: 1US FAERS
662Wheelchair userFAERS: 1US FAERS
663Wound infection staphylococcalFAERS: 1US FAERS
664Abnormal visionSIDER
665Acute Coronary SyndromeSIDER
666Acute graft versus host disease in liverOFFSIDES
667Acute psychosisOFFSIDES
668Adrenal cortical hypofunctionSIDER
669AkathisiaSIDER
670AlbuminuriaSIDER
671Anaphylactoid ReactionSIDER
672AnhedoniaOFFSIDES
673Anorectal cellulitisOFFSIDES
674Antithrombin III decreasedOFFSIDES
675Antiviral drug level above therapeuticOFFSIDES
676Arteriovenous fistula site complicationOFFSIDES
677Atrial arrhythmiaSIDER
678Autoimmune hepatitisOFFSIDES
679BK virus infectionOFFSIDES
680Bacterial EndocarditisOFFSIDES
681BicytopeniaOFFSIDES
682Blighted ovumSIDER
683Blood and lymphatic system disordersSIDER
684Blood cholesterol increasedSIDER
685Blood urea increasedOFFSIDES
SIDER
686Blurred visionOFFSIDES
687Bone marrow depressionSIDER
688Bone marrow toxicityOFFSIDES
689BronchiolitisCanada Vigilance: 1Canada Vigilance
690Bronchoalveolar LavageOFFSIDES
691Bronchopulmonary diseaseOFFSIDES
692Carbon dioxide abnormalOFFSIDES
693CardiomegalySIDER
694Catheter site erythemaOFFSIDES
695Central Nervous System InfectionOFFSIDES
696Cerebral artery stenosisOFFSIDES
697Chemotherapeutic drug level increasedOFFSIDES
698Chest tightnessSIDER
699Clostridium difficile colitisOFFSIDES
700Color vision changeSIDER
701Compression fractureOFFSIDES
702ConfabulationOFFSIDES
703ConjunctivitisSIDER
704Corneal OpacitySIDER
705Cramps of lower extremitiesSIDER
706Creatine Phosphokinase IncreasedSIDER
707Creatinine increasedSIDER
708Cystitis viralOFFSIDES
709Cytomegalovirus test positiveOFFSIDES
710DermatitisSIDER
711Disturbance in sexual arousalSIDER
712DiverticulumOFFSIDES
713DrowsinessOFFSIDES
714Duodenal ulcer perforationSIDER
715DuodenitisSIDER
716Ear and labyrinth disordersSIDER
717Electrocardiogram QT corrected intervalSIDER
718EndocarditisOFFSIDES
SIDER
719Engraft failureOFFSIDES
720Enlargement abdomenSIDER
721EpidermolysisOFFSIDES
722EpididymitisSIDER
723Epstein-Barr virus associated lymphoproliferative disorderOFFSIDES
724Febrile bone marrow aplasiaOFFSIDES
725Febrile infectionCanada Vigilance: 1Canada Vigilance
726FibromyalgiaOFFSIDES
727Fixed drug eruptionSIDER
728Flank PainSIDER
729FlatulenceSIDER
730Fluid overloadSIDER
731Fungemia24366741CTD
732FurunculosisSIDER
733Fusariosis22225407CTD
734Gingival HyperplasiaOFFSIDES
SIDER
735GingivitisSIDER
736Granulocyte count decreasedOFFSIDES
737GranulocytosisOFFSIDES
738GranulomaSIDER
739Hallucinations18574651
19540418
CTD
740Hepatic InfectionOFFSIDES
741Herpes NOSSIDER
742HiccoughOFFSIDES
743HydrocephalusOFFSIDES
744HydronephrosisSIDER
745HydropneumothoraxOFFSIDES
746Hypercalcemia16263588CTD
747HyperthyroidismSIDER
748Hyponatremia20567873CTD
749HypopyonOFFSIDES
750HysterectomyOFFSIDES
751InfestationSIDER
752Influenza-like symptomsSIDER
753Injection Site ReactionSIDER
754Injection site infectionSIDER
755Injection site painSIDER
756Intestinal PerforationSIDER
757Invasive Pulmonary Aspergillosis19011270CTD
758KeratitisSIDER
759KeratoconjunctivitisSIDER
760Kidney Diseases20567873CTD
761Kidney FailureOFFSIDES
762Leukopenia neonatalOFFSIDES
763Lip erosionOFFSIDES
764LipaseOFFSIDES
765Lung infection pseudomonalOFFSIDES
766LymphangitisSIDER
767Mechanical ventilationCanada Vigilance: 1Canada Vigilance
768MelanosisSIDER
769MetrorrhagiaSIDER
770MicrocytosisSIDER
771Muscle Weakness16410267CTD
OFFSIDES
772Musculoskeletal discomfortSIDER
773Mycetoma22205798
22760037
CTD
774Mycoses12149384
17015631
23964828
CTD
775MyelodysplasiaOFFSIDES
776MyopathySIDER
777NephritisSIDER
778Nephrogenic Diabetes InsipidusOFFSIDES
779NephrosisSIDER
780Nerve BlockOFFSIDES
781Neuroaspergillosis19827595CTD
782Neutropenic infectionOFFSIDES
783Ocular ToxicityCanada Vigilance: 1Canada Vigilance
784OculogyrationSIDER
785Oculogyric crisisSIDER
786Open reduction of fractureOFFSIDES
787Optic AtrophySIDER
788Oropharyngeal discomfortSIDER
789OsteomalaciaSIDER
790OsteoporosisOFFSIDES
SIDER
791Otitis ExternaSIDER
792Pelvic PainSIDER
793PeriodontitisSIDER
794Peripheral Nervous System Diseases

View details

CTD
795Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
796PhlebitisSIDER
797Pneumonia herpes viralOFFSIDES
798ProctitisSIDER
799Product substitution issueCanada Vigilance: 1Canada Vigilance
800Product use complaintCanada Vigilance: 1Canada Vigilance
801Protein urine presentSIDER
802ProteinuriaSIDER
803Pseudotumor Cerebri21071321CTD
804PsoriasisSIDER
805Pulmonary Aspergillosis19457596CTD
806PurulenceOFFSIDES
807Renal tubular necrosisSIDER
808Respiratory Distress SyndromeSIDER
809RetchingCanada Vigilance: 1Canada Vigilance
810RetinitisSIDER
811Retrosternal painSIDER
812RhinitisSIDER
813SclerodermaOFFSIDES
814ScotomaSIDER
815Stenotrophomonas infectionOFFSIDES
816SweatingSIDER
817Synovial CystOFFSIDES
818Systemic candidiasis19141735CTD
819Tachycardia, Ventricular15472801CTD
820Therapeutic product effect incompleteCanada Vigilance: 1Canada Vigilance
821ThrombophlebitisSIDER
822Tooth ExtractionOFFSIDES
823Transaminases abnormalOFFSIDES
824Traumatic liver injurySIDER
825UremiaSIDER
826Vascular purpuraSIDER
827Ventricular bigeminySIDER
828VertigoSIDER
829Vision Disorders18466103
18574651
CTD
830furuncleSIDER
831microcyticSIDER
832prostatitisOFFSIDES
833pseudomembranous colitisSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.